Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Operating Expenses: 2022-2024

Historic Operating Expenses for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to $137.9 million.

  • Stoke Therapeutics' Operating Expenses rose 53.95% to $53.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.4 million, marking a year-over-year increase of 33.12%. This contributed to the annual value of $137.9 million for FY2024, which is 11.63% up from last year.
  • According to the latest figures from FY2024, Stoke Therapeutics' Operating Expenses is $137.9 million, which was up 11.63% from $123.6 million recorded in FY2023.
  • In the past 5 years, Stoke Therapeutics' Operating Expenses registered a high of $137.9 million during FY2024, and its lowest value of $116.8 million during FY2022.
  • Moreover, its 3-year median value for Operating Expenses was $123.6 million (2023), whereas its average is $126.1 million.
  • Data for Stoke Therapeutics' Operating Expenses shows a peak YoY grew of 11.63% (in 2024) over the last 5 years.
  • Stoke Therapeutics' Operating Expenses (Yearly) stood at $116.8 million in 2022, then rose by 5.82% to $123.6 million in 2023, then grew by 11.63% to $137.9 million in 2024.